Is the 40,000-share Pulmonx (LUNG) award to Dana Mead a market purchase?

No, the 40,000 Pulmonx shares are a grant of Restricted Stock Units, not a market purchase. The RSUs represent equity compensation awarded at a zero purchase price and will convert into common stock once vesting conditions are met.

Pulmonx (LUNG) director receives 40,000-share RSU stock grant

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Mead Dana G Jr. reported acquisition or exercise transactions in this Form 4 filing.

Pulmonx Corp director Dana G. Mead Jr. received a grant of 40,000 Restricted Stock Units payable in common stock. This is a stock-based compensation award, not an open-market purchase.

The RSUs vest on the earlier of June 5, 2026 or the company’s next annual stockholder meeting. After this grant, Mead holds 139,714 Pulmonx common shares directly and 4,076 shares indirectly through The Mead Family Trust.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Mead Dana G Jr.

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	40,000	$0.00	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 139,714 shares (Direct, null); Common Stock — 4,076 shares (Indirect, See footnote)

Footnotes (1)

Represents grant of Restricted Stock Units ("RSU Grant") payable solely in common stock of the Issuer that vest on the earlier of (i) the one-year anniversary of the date of grant of June 5, 2026, or if such date is not a business day, then on the next business day, or (ii) the date of the Annual Meeting of the Stockholders for the year subsequent to the date such RSU Grant is made. The shares are held directly by the Dana G. Mead, Jr. And D'Arcy Gage Mead, or Their Successors, as Trustees of The Mead Family Trust Created Uta Dated August 4, 1998, as Amended.

Key Figures

RSU grant size: 40,000 shares RSU grant price: $0.00 per share Direct holdings after grant: 139,714 shares +2 more

5 metrics

RSU grant size 40,000 shares Restricted Stock Units payable in Pulmonx common stock

RSU grant price $0.00 per share Equity compensation grant, not a market purchase

Direct holdings after grant 139,714 shares Pulmonx common stock held directly by Dana G. Mead Jr.

Indirect holdings 4,076 shares Held by The Mead Family Trust as reported in footnote

RSU vesting date trigger June 5, 2026 Vests on earlier of this date or next annual stockholder meeting

Key Terms

Restricted Stock Units, Annual Meeting of the Stockholders, non-derivative, indirect, +1 more

5 terms

Restricted Stock Units financial

"Represents grant of Restricted Stock Units ("RSU Grant") payable solely in common stock of the Issuer"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Annual Meeting of the Stockholders financial

"or (ii) the date of the Annual Meeting of the Stockholders for the year subsequent"

non-derivative financial

"transaction_type": "non-derivative""

indirect financial

""ownership_type": "indirect""

nature of ownership financial

""nature_of_ownership": "See footnote""

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

06/09/2026 - 05:49 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mead Dana G Jr.

(Last)

(First)

(Middle)

C/O PULMONX CORPORATION

700 CHESAPEAKE DRIVE

(Street)

REDWOOD CITY

CALIFORNIA

94063

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Pulmonx Corp [ LUNG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	06/05/2026		A		40,000⁽¹⁾	A	$0	139,714	D
Common Stock								4,076	I	See footnote⁽²⁾

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents grant of Restricted Stock Units ("RSU Grant") payable solely in common stock of the Issuer that vest on the earlier of (i) the one-year anniversary of the date of grant of June 5, 2026, or if such date is not a business day, then on the next business day, or (ii) the date of the Annual Meeting of the Stockholders for the year subsequent to the date such RSU Grant is made.

2. The shares are held directly by the Dana G. Mead, Jr. And D'Arcy Gage Mead, or Their Successors, as Trustees of The Mead Family Trust Created Uta Dated August 4, 1998, as Amended.

	/s/ David Aaron Lehman, Attorney-in-Fact	06/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Dana G. Mead Jr. report in the latest Pulmonx (LUNG) Form 4?

Dana G. Mead Jr. reported receiving 40,000 Restricted Stock Units as a stock-based award. These RSUs are payable in Pulmonx common stock and increase his direct holdings to 139,714 shares, plus 4,076 shares held indirectly through The Mead Family Trust.

When do Dana Mead’s new Pulmonx (LUNG) RSUs vest?

The 40,000 Pulmonx Restricted Stock Units vest on the earlier of June 5, 2026, or the date of the company’s next annual stockholder meeting. Vesting timing is therefore tied to either a one-year anniversary or the upcoming annual meeting schedule.

How many Pulmonx (LUNG) shares does Dana Mead hold after this Form 4?

Following the RSU grant, Dana Mead holds 139,714 Pulmonx common shares directly. He also has an indirect interest in 4,076 shares held by The Mead Family Trust, which together reflect the equity position reported in this Form 4 filing.

What is the exercise or purchase price of Dana Mead’s Pulmonx (LUNG) RSU grant?

The 40,000 Pulmonx Restricted Stock Units were granted at a price of $0.00 per share. This indicates they are part of equity compensation, where shares are delivered upon vesting without requiring a cash payment from the recipient.

How are some of Dana Mead’s Pulmonx (LUNG) shares held indirectly?

An indirect holding of 4,076 Pulmonx shares is reported as held by The Mead Family Trust. The Form 4 states the shares are held by trustees of The Mead Family Trust created under an August 4, 1998 trust agreement, as amended.